1. Long‐term success of a multi‐electrode substrate mapping and ablation strategy versus a classic single tip mapping and ablation strategy for ventricular tachycardia ablation in patients with ischemic cardiomyopathy.
- Author
-
Balt, Jippe C., Abeln, Bob G. S., Mahmoodi, Bakhtawar K., van Dijk, Vincent F., Wijffels, Maurits C. E. F., and Boersma, Lucas V. A.
- Subjects
- *
STATISTICS , *ANTERIOR wall myocardial infarction , *VENTRICULAR ejection fraction , *MYOCARDIAL ischemia , *CARDIOMYOPATHIES , *LOG-rank test , *MULTIVARIATE analysis , *CATHETER ablation , *SURGICAL complications , *IMPLANTABLE cardioverter-defibrillators , *MAGNETIC resonance imaging , *VENTRICULAR tachycardia , *TREATMENT effectiveness , *COMPARATIVE studies , *DISEASE relapse , *DESCRIPTIVE statistics , *PROGRESSION-free survival , *LONGITUDINAL method , *DISEASE complications , *EVALUATION - Abstract
Introduction: Over the past years, mapping and ablation techniques for the treatment of ventricular tachycardia (VT) have evolved rapidly. High Density (HD) substrate mapping is now routine and pre‐procedural imaging is increasingly used. The additional value of these techniques for long‐term VT‐free survival is not clear. Methods: We compared baseline and procedural characteristics, procedural success, safety and outcome of mapping and ablation of ventricular tachycardia in patients with ischemic heart disease between two groups. (1) Low Density (LD) group: VT mapping and ablation with a 4 mm single tip catheter (2) HD group: HD substrate mapping with the Pentaray (Biosense Webster, USA) or HD Grid (Abbott, USA) catheter and ablation with a 4 mm single tip catheter. Results: VT ablation was performed in 133 patients (71 patients in LD group and 62 patients in HD group). The median follow‐up was 5.0 years in LD group and 2.0 years in HD group. One‐, two‐, and five‐year VT recurrence rates were 47%, 56%, and 65% in the LD group versus 39%, 50%, and 55% in the HD group (log‐rank test for VT recurrence p =.70). One‐, two‐, and five‐year ICD shock recurrence rates were 14%, 18%, and 24% in the LD group versus 8%, 15%, and 19% in the HD group (log‐rank test for ICD‐shock p =.79). All‐cause mortality, cardiac (non‐arrhythmic), and arrhythmic death, were similar in both groups. Severe procedural complications (tamponade, stroke, or procedural death) occurred in four patients (5%, 1 vascular, 3 tamponade) in the LD group versus two patients (3%, both tamponade) in the HD group (NS). In univariate and multivariable analysis, only a higher LVEF was significantly associated with VT‐free survival. HD mapping was not significantly associated with VT‐free survival. Anterior infarct location and age were significantly associated with ICD recurrent shock in both univariate and multivariable analyses. Conclusions: In patients with ischemic cardiomyopathy, a HD substrate mapping, and ablation strategy did not lead to higher VT‐free survival and shock‐free survival compared to a single tip mapping and ablation strategy. In this study, only LVF is an independent predictor for VT recurrence. Anterior infarct location and age predict recurrent ICD shocks. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF